BCDA 8-K 2026-11-06

BioCardia, Inc. (BCDA) 8-K dated 2026-11-06 — accession 0001437749-26-035408.

BioCardia, Inc. (BCDA) is a biotechnology company listed on NASDAQ.

BioCardia, Inc. filed a 8-K on 2026-11-06. Accession 0001437749-26-035408.

This 8-K covers: Other events (Item 8.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported BCDA revenue for 2025-12-31 was $0. Net income was -$8.2M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. BCDA currently screens at market cap $14.4M.

Not investment advice. The BCDA SEC hub lists recent forms. The stock page is the research view.